Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
The competition watchdog CCI on Tuesday approved Fortis Healthcare's proposal to acquire an additional 31.52 per cent stake in Agilus Diagnostics. Multi-speciality hospital chain Fortis Healthcare Ltd (FHL) is engaged in providing integrated healthcare delivery services like medicare, healthcare and diagnostics. The diagnostics services business of FHL is being undertaken primarily through Agilus. "Commission approves the acquisition of additional 31.52 per cent share capital of Agilus Diagnostics Ltd by Fortis Healthcare Ltd," according to a post by CCI on X. After the transaction, the shareholding of Fortis Healthcare Ltd (FHL) in Agilus will increase from 57.68 per cent to 89.2 per cent. In August, Fortis Healthcare announced that it will acquire a 31 per cent stake in Agilus Diagnostics for Rs 1,780 crore valuing Agilus at Rs 5,700 crore. The Competition Commission of India (CCI) has also cleared the proposed merger of Diliigent Power into DB Power, and the reorganisation of
Easing of pressure from predatory pricing and steady network expansion is boosting growth for diagnostics companies, say Abdulkader Puranwala and Nisha Shetty of ICICI Securities
The projected rise in revenue comes on the back of an estimated 8% growth in FY24
The participation aims to add to the diagnostic service provider's international portfolio. Its international network consists of several centres and pick-up points (PUPs) across multiple locations
Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services
It may be possible to detect signs of Parkinson's disease 20-30 years before symptoms appear, according to researchers in Australia. A biomarker called F-AV-133, used in combination with PET, or positron emission tomography, scans can help diagnose Parkinson's disease and accurately track neurodegeneration, the researchers from the Florey Institute of Neuroscience and Mental Health, Melbourne, said. F-AV-133 is an imaging agent and has shown promise as a PET tracer for detecting and monitoring neurodegeneration in Parkinson's disease, a progressive neurological disorder characterised by tremor and impaired muscular coordination. According to the researchers, the disease, often thought of as an illness of old age, in fact, starts in midlife and can go undetected for decades. "Parkinson's disease is very hard to diagnose until symptoms are obvious, by which time up to 85 per cent of the brain's neurons that control motor coordination have been destroyed. At that point, many treatment
Dilip filed a complaint before the Delhi State Commission, alleging that the RFA procedure was carried out without his knowledge or consent, and also without considering the findings of the EPS
Med-tech companies are working round the clock to come up with AI-based solutions
Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility
"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation
A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors
Promoters are focused on strengthening the Metropolis brand, although it continuously keeps exploring various strategic options/investment opportunities
Dr Lal PathLabs is India's largest diagnostic services player by revenue, with 289 laboratories across the country
Announced foray into fragmented diagnostic business where organised chains have less than 20% share of overall business
Patna police have raided a plasma diagnostic lab and seized a large number of fake RT-PCR Covid-19 reports, police said.
The company is planning to set up 10 more labs in the northern and eastern parts of the country for deeper penetration
The RT-PCR tests will carry on, and the massive vaccination drive will require lakhs of antibody tests to check for immunity
Lower surgeries and rising costs also likely to impact earnings; valuations too are rich
India on Wednesday reported a spike of 9,985 more COVID-19 cases in the last 24 hours, taking the country's COVID-19 count to 2,76,583, according to the Union Ministry of Health and Family Welfare
Firm will be scaling up its capacity up to 2,000-2,500 tests a day as per ICMR norms by next week